Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 29, 2019
Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up
Matthew S Ning, Brian J Deegan, Jennifer C Ho, et al.
Journal of Neurosurgery. Spine
|
February 15, 2020
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience
David Boyce-Fappiano, Olsi Gjyshi, Todd A Pezzi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2025
Long-term Results From a phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Spinal Metastases With Epidural Extension
Amol J Ghia, Nandita Guha-Thakurta, Mark F Munsell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care
Matthew S Ning, Prajnan Das, David I Rosenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
Cancers
|
February 13, 2025
Advanced External Beam Stereotactic Radiotherapy for Skull Base Reirradiation
He Wang, Fahed M Alsanea, Dong Joo Rhee, et al.
Advances in Radiation Oncology
|
April 7, 2021
Our Experience Leading a Large Medical Physics Practice During the COVID-19 Pandemic
Julianne M Pollard-Larkin, Tina M Briere, Rajat J Kudchadker, et al.
Journal of Medicinal Chemistry
|
January 18, 2022
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of <i>MTAP</i>-Deleted Cancers
Christopher R Smith, Ruth Aranda, Thomas P Bobinski, et al.
Journal of Medicinal Chemistry
|
July 14, 2022
Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction
John M Ketcham, Jacob Haling, Shilpi Khare, et al.
Cancer Research
|
July 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 29, 2019
Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up
Matthew S Ning, Brian J Deegan, Jennifer C Ho, et al.
Journal of Neurosurgery. Spine
|
February 15, 2020
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience
David Boyce-Fappiano, Olsi Gjyshi, Todd A Pezzi, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2025
Long-term Results From a phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Spinal Metastases With Epidural Extension
Amol J Ghia, Nandita Guha-Thakurta, Mark F Munsell, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 20, 2021
Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care
Matthew S Ning, Prajnan Das, David I Rosenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
Marcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
Cancers
|
February 13, 2025
Advanced External Beam Stereotactic Radiotherapy for Skull Base Reirradiation
He Wang, Fahed M Alsanea, Dong Joo Rhee, et al.
Advances in Radiation Oncology
|
April 7, 2021
Our Experience Leading a Large Medical Physics Practice During the COVID-19 Pandemic
Julianne M Pollard-Larkin, Tina M Briere, Rajat J Kudchadker, et al.
Journal of Medicinal Chemistry
|
January 18, 2022
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of <i>MTAP</i>-Deleted Cancers
Christopher R Smith, Ruth Aranda, Thomas P Bobinski, et al.
Journal of Medicinal Chemistry
|
July 14, 2022
Design and Discovery of MRTX0902, a Potent, Selective, Brain-Penetrant, and Orally Bioavailable Inhibitor of the SOS1:KRAS Protein-Protein Interaction
John M Ketcham, Jacob Haling, Shilpi Khare, et al.
Cancer Research
|
July 22, 2025
Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer
Kristina Drizyte-Miller, Lars D Engstrom, Jeffrey A Klomp, et al.
Page
of 8